Cargando…

Evaluation of HPV E6/E7 mRNA Detection in Clinically Suspected Cases of Cervical Cancer with Abnormal Cytology: Time to Upgrade the Screening Protocols

Background Human papillomavirus (HPV) E6/E7 mRNA tests determine the oncogenic activity of the virus and represent a good clinical biomarker for predicting the risk of cervical cancer. So, the present study was conducted to know the role of HPV E6/E7 mRNA as a predictive biomarker for cervical carc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sharma, Bhawna, Lakhanpal, Vikas, Singh, Kanwardeep, Oberoi, Loveena, Bedi, Preet Kamal, Devi, Pushpa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Thieme Medical and Scientific Publishers Pvt. Ltd. 2022
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9473935/ https://www.ncbi.nlm.nih.gov/pubmed/36119422 http://dx.doi.org/10.1055/s-0042-1748919

Ejemplares similares

Do women with high-risk HPV E6/E7 mRNA test positivity and NILM cytology need colposcopy?
por: Liu, Ying, et al.
Publicado: (2023)

Hepatitis E virus: A leading cause of waterborne viral hepatitis in Northwest Districts of Punjab, India
por: Kaur, Maninder, et al.
Publicado: (2017)

HPV-specific risk assessment of cervical cytological abnormalities
por: Zhong, Guanglei, et al.
Publicado: (2021)

Prevalence of “unclassified” HPV genotypes among women with abnormal cytology
por: Annunziata, Clorinda, et al.
Publicado: (2018)

HPV E6/E7 mRNA Testing Is More Specific than Cytology in Post-Colposcopy Follow-Up of Women with Negative Cervical Biopsy
por: Sørbye, Sveinung Wergeland, et al.
Publicado: (2011)

HPV genotype determination and E6/E7 mRNA detection for management of HPV positive women
por: Bruno, Maria Teresa, et al.
Publicado: (2018)

Cervical cytological abnormalities and HPV infection in perinatally HIV–infected adolescents
por: Ananworanich, J, et al.
Publicado: (2015)

HPV prevalence and type distribution in Cypriot women with cervical cytological abnormalities
por: Krashias, George, et al.
Publicado: (2017)

The Expression of HPV E6/E7 mRNA In Situ Hybridization in HPV Typing-negative Cervical Cancer
por: Xu, Yating, et al.
Publicado: (2023)

Presence of High-Risk HPV mRNA in Relation to Future High-Grade Lesions among High-Risk HPV DNA Positive Women with Minor Cytological Abnormalities
por: Johansson, Hanna, et al.
Publicado: (2015)

High prevalence of HPV in non-cervical sites of women with abnormal cervical cytology
por: Crawford, Robin, et al.
Publicado: (2011)

hr-HPV testing in the follow-up of women with cytological abnormalities and negative colposcopy
por: Carozzi, F, et al.
Publicado: (2013)

HPV genotype distribution among women with normal and abnormal cervical cytology in Turkey
por: Muderris, Tuba, et al.
Publicado: (2019)

The Impact of HPV Diagnosis and Abnormal Cervical Cytology Results on Sexual Dysfunction and Anxiety
por: Aker, Seda Şahin, et al.
Publicado: (2023)

Triage of HR-HPV Positive Women with Minor Cytological Abnormalities: A Comparison of mRNA Testing, HPV DNA Testing, and Repeat Cytology Using a 4-Year Follow-Up of a Population-Based Study
por: Persson, Maria, et al.
Publicado: (2014)

14-type HPV mRNA test in triage of HPV DNA-positive postmenopausal women with normal cytology
por: Asciutto, Katrin Christine, et al.
Publicado: (2020)

HPV16 E6/E7 -based mRNA vaccine is therapeutic in mice bearing aggressive HPV-positive lesions
por: Zhou, Kun, et al.
Publicado: (2023)

Cervical and anal HPV infection: cytological and histological abnormalities in HIV-infected women in Thailand
por: Ramautarsing, Reshmie A, et al.
Publicado: (2015)

Predictors of abnormal cytology among HPV-infected women in remote territories of French Guiana
por: Adenis, Antoine, et al.
Publicado: (2018)

Predictive Value of HPV E6/E7 mRNA Detection on the Outcome of Cervical LSIL
por: Cao, Limei, et al.
Publicado: (2022)

Diagnostic value of high-risk HPV E6/E7 mRNA in patients with ASCUS
por: Jin, Xiu, et al.
Publicado: (2023)

The integration of HR-HPV increases the expression of cyclins A and E in cytologies with and without low-grade lesions
por: Zubillaga-Guerrero, MI, et al.
Publicado: (2013)

Prevalence of Abnormal Anal Cytology in Women with Abnormal Cervical Cytology
por: Inthasorn, Perapong, et al.
Publicado: (2021)

Long-term CIN3+ risk in women with abnormal cytology; role of hrHPV testing
por: Kocken, M, et al.
Publicado: (2012)

HPV E6/E7 mRNA transcripts as predictors of high-grade epithelial cervix dysplasia
por: Möckel, J, et al.
Publicado: (2007)

The Potential Benefits of HPV E6/E7 mRNA Test in Cervical Cancer Screening in China
por: Zhang, Shao-Kai, et al.
Publicado: (2020)

HPV E6/E7 mRNA in situ hybridization in endocervical adenocarcinoma: implications for prognosis and diagnosis
por: Luo, Rong-Zhen, et al.
Publicado: (2021)

Retracted: Predictive Value of HPV E6/E7 mRNA Detection on the Outcome of Cervical LSIL
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

13-Type HPV DNA Test versus 5-Type HPV mRNA Test in Triage of Women Aged 25–33 Years with Minor Cytological Abnormalities–6 Years of Follow-Up
por: Rad, Amir, et al.
Publicado: (2023)

The Impact of High-Risk HPV Genotypes Other Than HPV 16/18 on the Natural Course of Abnormal Cervical Cytology: A Korean HPV Cohort Study
por: So, Kyeong A, et al.
Publicado: (2016)

Rare Breast Malignancy Subtypes: A Cytological, Histological, and Immunohistochemical Correlation
por: Kaur, Manmeet, et al.
Publicado: (2019)

Diagnostic Utility of HPV16 E6 mRNA or E7 mRNA Quantitative Expression for Cervical Cells of Patients with Dysplasia and Carcinoma
por: Wu, Ming-Zhe, et al.
Publicado: (2018)

HPV presence precedes abnormal cytology in women developing cervical cancer and signals false negative smears
por: Zielinski, G D, et al.
Publicado: (2001)

Human Papillomavirus (HPV) Type Distribution in Females with Abnormal Cervical Cytology. A Correlation with Histological Study
por: Cobo, Fernando, et al.
Publicado: (2009)

Minor Cytological Abnormalities and up to 7-Year Risk for Subsequent High-Grade Lesions by HPV Type
por: Persson, Maria, et al.
Publicado: (2015)

Role of genomic DNA methylation in detection of cytologic and histologic abnormalities in high risk HPV-infected women
por: Dankai, Wiyada, et al.
Publicado: (2019)

An efficient method that combines the ThinPrep cytologic test with E6/E7 mRNA testing for cervical cancer screening
por: Pan, Dan, et al.
Publicado: (2019)

HPV E2, E4, E5 drive alternative carcinogenic pathways in HPV positive cancers
por: Ren, Shuling, et al.
Publicado: (2020)

Triage of Women with Low-Grade Cervical Lesions - HPV mRNA Testing versus Repeat Cytology
por: Sørbye, Sveinung Wergeland, et al.
Publicado: (2011)

Accuracy of HPV E6/E7 mRNA examination using in situ hybridization in diagnosing cervical intraepithelial lesions
por: Hui, Chang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_a5lpcne7l82emm0km6c1e7nsjs